2020 Poster Titles
Room: Hall B
Poster Presenters noted with * are Student Fellows.
AbbVie, Inc.
1. Deep Learning Applications in Advancing Drug Development; Presented by Liuqing Y.
Academia Sinica
2.
Integrated Devices for Rare Cell Isolation and Sensing; Presented by Peilin C.
Academia Sinica
3. A Panel of Anti-Influenza Virus Nucleoprotein Antibodies Selected
from Phage-Displayed Synthetic Antibody Libraries with Rapid Diagnostic Capability to Distinguish Diverse Influenza Virus Subtypes; Presented by An-Suei Y.
AligND Systems AB
4.
Enhanced Fluorescence Detection of Proteins Using Nanowires; Presented by Søren E.
AligND Systems AB
5. Fluorescence Signal Enhancement Using Lightguiding Nanowires
for Biosensing Applications; Presented by Søren E.
Amgen, Inc.
6. Integrated Tool Suite for Biologics Design Enables High-Throughput Drug Discovery; Presented by Michelle H.
Amgen, Inc.
7. Development of Informatics Pipeline for Screening Analysis via High Throughput Affinity Mass Spectrometry; Presented by Dylan O.
AmpTec GmbH
8. Synthetic mRNAs in Multiple Clinical Trials: AmpTec as Manufacturer of High Quality GMP-Grade Synthetic mRNAs; Presented by Guido K.
AMS Biotechnology (Europe) Ltd.
9. ONCO-Chip3D Technology: A Microfluidic Platform for Physiologically Relevant Drug Screening and Precision Medicine; Presented by Alexander S.
Aspen Biosciences
10. The Secret Names of Things: Using Metadata to Improve Pharmaceutical Collaboration; Presented by Mark F.
Avacta Life Sciences
11. Turning
a Negative to a Positive with Anti-Metatype Affimer® Reagents; Presented by Matt J.
Aventior, Inc.
12. Unstructured Data Extraction and Metadata Management Using AI Based
Tools - DRIP and CPV; Presented by Abhijit R.
Aventior, Inc.
13. Digital Pathology: Label Extraction Using AI; Presented by Abhijit R.
BioIVT
14. BioIVT Triple Format (FFPE/FF, CNB/FNA) Specimen Collection for Diagnostic Assay Development; Presented by Lauren M.
BioIVT
15. Metrics
for Assessing Biospecimen Selection and Processing for Successful NGS Outcomes; Presented by Tracey Z.
Bioneer Corporation
16. High-Throughput Cell-Free DNA Extraction System
for Biopsy; Presented by Yeaseong H.
Bristol-Myers Squibb Company
17. Biomarker 360: Empowering Knowledge and Data Driven Biomarker Decision Making to Drive Translational Medicine;
Presented by Christopher W.
Broad Institute of MIT and Harvard
18. Development of Multiplexed CRISPR-Based Diagnostics for Tick-Borne Disease; Presented by Jon A.*
Centre Hospitalier Andrée Rosemon
19. Implementation of POCT in Public Health Centers in French Guiana; Presented by Alexandra M.
Claret Bioscience LLC
20. SRSLY™: An Efficient, Single-Strand Ligation-Based Approach for NGS Library Preparation from Highly Fragmented DNA; Presented by Varsha R.
Creatv MicroTech, Inc.
21.
Circulating Stromal Cells and Cell Free DNA Increases Sensitivity in Profiling Oncogenic Mutations While Indicating Highly Aggressive Non-Small Cell Lung Cancer; Presented by Daniel A.
Creatv MicroTech, Inc.
22.
Training and Validation for Sequential Monitoring of Circulating Stromal Cells for Predicting Progression in NSCLC Cancer Patients Undergoing Definitive Radiotherapy; Presented by Daniel A.
DiaCarta, Inc.
23.
XNA-Based OptiSeq Dual Cancer Panel, a Highly Sensitive and Reproducible Method for Early Detection of Cancer; Presented by Zhen C.
DiaCarta, Inc.
24. A Highly Sensitive and
User-Friendly Assay for BRAF V600 Mutation Detection; Presented by Yulei S.
DiaCarta, Inc.
25. A Novel XNA-Based Multiplex qPCR Panel Assay for Colorectal Cancer Mutation Detection;
Presented by Qing S.
Duke University
26. A Low-Cost Point of Care Diagnostic Fluorescent Microarray Scanner; Presented by Jason L.*
Duke University
27. Detecting the Decoy: D4 Immunoassay Targeting Ebola's Secreted Glycoprotein Yields Earlier than PCR Detection of Infection; Presented by Cassio F.*
Duke University
28.
Cellular and Molecular Credentialing of Breast Tumor HER2 Status Using a Cell Phone; Presented by Jacob H.*
Duke University
29. A Portable Point-of-Care Platform for Rapid Diagnosis
and Screening of Fungal Talaromycosis Infection; Presented by David K.*
Duke University
30. Point-of-Care Plasmonically Enhanced Immunoassay for Early Detection of Heart Failure;
Presented by Daria S.*
Food and Drug Administration
31. In Vitro Modeling of Circulating Tumor Cells Towards Novel Cancer Biomarkers; Presented by Julianne T.
Forschungszentrum Jülich
32. Small-Molecule Modulators of TRMT2a Decrease PolyQ Aggregation and PolyQ-Induced Cell Death; Presented by Michael M.*
Hitachi High Technologies America, Inc.
33.
Virtual Screening to Discover Probable Compounds' Spaces Based on Mixture of Mutated Exemplars and Bioassay Existence Ratio; Presented by Takashi I.
Horizon Discovery
34. A Comparison
of Different Formats of DNA Reference Standards Commutable with Solid and Liquid Biopsy Samples for Cancer Genomic Profiling; Presented by Jesse S.
Horizon Discovery
35. Development
of cfDNA Reference Standards that Are Compatible with Commonly Used Extraction Methods and Molecular Assays; Presented by Julie W.
immunoSCAPE
36. Immuno-Phenotyping of Tumor-Specific
CD8 T Cells Using High-Dimensional Mass Cytometry; Presented by Brian A.
IQVIA
37. Impact of Tumour Genomic Characteristics on Healthcare Resource Utilisation and Real-World Outcomes
in Patients with Non-Small Cell Lung Cancer: A Real World Study Using Linked Whole Genome-Clinical Databases; Presented by Mike G.
Johns Hopkins University
38. Bisulfite-Converted
Duplexes for the Strand-Specific Detection and Quantification of Rare Mutations; Presented by Austin M.*
Keen Eye Technologies
39. Diagnosing and Subtyping Lung Cancer Using Deep
Learning on Whole Slide Images; Presented by Sylvain B.
Koo Foundation Sun-Yat Sen Cancer Center
40. Circulating Tumor DNA as a Prognostic Biomarker in Metastatic Breast Cancer;
Presented by Yong W.
Korea Institute of Machinery and Materials
41. Microfluidic Condensation Sampler for Collection of Nanoscale Airborne Particles; Presented by Kwanoh K.
LCM Biosensor Technologies
42. Monitoring Osmotic Pressure of Intercellular Substance in Prevention of Chronic Disease; Presented by Ramil M.
miDiagnostics
43. The World's Most Compact Complete Blood Count Prototype Ever Built; Presented by Christopher A.
NanoView Biosciences
44. Exosome Biomarkers:
Multiparametric Characterization and Phenotypic Analysis; Presented by Clayton D.
National University of Singapore
45. Companion Diagnostics for Trastuzumab-Based Neoadjuvant
Therapy - Two Is Better than One; Presented by Yoon Pin L.
New York Genome Center
46. GenomeDiver - Keeping the Human in the Loop; Presented by Christian S.
Nottingham Trent University
47. The Design and Development of Electronic Textiles for Health Monitoring Applications; Presented by Theodore H.
NVIGEN, Inc.
48. Comparative
Study of Matrix Effects and Extraction Methods on Assay Sensitivity Validation Samples Contrived with Human Plasma; Presented by Aihua F.
NVIGEN, Inc.
49. Achieving State-of-the-Art
Nucleic-Acid Detection Accuracy in qPCR with Help of Deep Convolutional Machines Learning Neural Networks; Presented by Aihua F.
NVIGEN, Inc.
50. High Yield Cell Free DNA Capture
and Diagnositics with Molecularly Engineered Magnetic Nanoparticles; Presented by Aihua F.
RareCyte, Inc.
51. Validation of an Assay to Detect Programmed Death-Ligand 1 (PD-L1)
Expression on Circulating Tumor Cells; Presented by Adrian Q.
RealSeq Biosciences, Inc.
52. Highly Sensitive Direct Quantification of cf-microRNAs for Biomarker Profiling by
Next Generation Sequencing (NGS); Presented by Sergio B.
Sandia National Laboratories
53. Thermodynamic Predictions of Primer Interactions and Impact on LAMP Assay Performance;
Presented by Robert M.
Schrödinger
54. An Automated Workflow to Identify Suitable Targets for Physics-Based Drug Discovery; Presented by Felicia G.
Seegene, Inc.
55. Analytical Performance and Workflow Comparisons of Seegene's Automation Platforms; Presented by Mira K.
Seegene, Inc.
56. The Development
of Cloud-Based Statistical Software for Monitoring Results of Multiplex Syndromic Assays; Presented by Eugene K.
Sookmyung Women’s University
57. Target Prediction and
Validation of Benzo[b]tellurophenes as a Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitor; Presented by Yoon-Jung K.*
Sookmyung Women’s University
58. Network-Based
Drug Repositioning Approaches of Phenoxazine-Linked Thiourea Analogues for Prevention of Osteoclastogenesis; Presented by Eun L.*
St. Jude Children's Research Hospital
59. Using
mHealth Apps to Improve Care for Patients with Sickle Cell Disease: Design of the mHealth Embedded in the Care of Sickle Cell Patients Who Take Hydroxyurea (mESH) Trial; Presented by Jane H.
Stanford University
60.
A Magnetoresistive Biosensor Assay for Detecting Circulating Tumor DNA in Non-Small Cell Lung Cancer; Presented by Katie A.*
Thermo Fisher Scientific
61. Development of an Expanded
Microsatellite Instability Panel with Automated Data Analysis; Presented by Charles B.
Thermo Fisher Scientific
62. Specific Capture of Nucleic Acids for Molecular Diagnostics
and mRNA-Based Therapeutics Applications Using Dynabeads™; Presented by Laure J.
Thermo Fisher Scientific
63. Next Generation DNase for Ultimate Performance in Therapeutic,
IVD and Molecular Biology Applications; Presented by Samantha L.
Thermo Fisher Scientific
64. Single-Use Based BioProduction Process for Manufacturing of High Quality Recombinant
Enzymes for mRNA and DNA Workflows; Presented by Samantha L.
Thermo Fisher Scientific
65. A High-Throughput Approach for Multi-Omic Testing for Prostate Cancer Research; Presented by Christopher T.
Tohoku University
66. Development of Ingestible Sensor Platform Based on Gastric Acid Battery; Presented by Shinya Y.
University of Chicago
67.
Using Indication Embeddings to Represent Patient Health for Drug Safety Studies; Presented by Rachel M.
University of Georgia
68. Tumor Antigen-Independent and Cell Size Variation-Inclusive
Enrichment of Viable Circulating Tumor Cells; Presented by Yang L.*
Vortex Biosciences, Inc.
69. An Integrated Workflow for the Automated Isolation, High Throughput Identification,
Enumeration and Characterization of Circulating Tumor Cells; Presented by Corinne R.
Wainamics, Inc.
70. Critical Components for Lab-on-a-Chip Product Development; Presented by Ming T.
X Gen US Co.
71. Novel Transposase Accelerates Liquid Biopsy Tests for cfDNA, cfRNA and CTCs; Presented by Andreas T.